Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-251590
Filing Date
2023-10-05
Accepted
2023-10-05 16:34:01
Documents
6
Effectiveness Date
2023-10-05

Document Format Files

Seq Description Document Type Size
1 S-8 d506674ds8.htm S-8 37822
2 EX-5.1 d506674dex51.htm EX-5.1 7903
3 EX-23.1 d506674dex231.htm EX-23.1 2080
4 EX-99.3 d506674dex993.htm EX-99.3 4115
5 EX-FILING FEES d506674dexfilingfees.htm EX-FILING FEES 16054
6 GRAPHIC g506674g1005110600266.jpg GRAPHIC 2325
  Complete submission text file 0001193125-23-251590.txt   72298
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-274878 | Film No.: 231311789
SIC: 2834 Pharmaceutical Preparations